<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biomedical and Pharmacology Journal</journalTitle>
          <issn>0974-6242</issn>
            <publicationDate>2017-06-20</publicationDate>
    
        <volume>10</volume>
        <issue>2</issue>

 
    <startPage>749</startPage>
    <endPage>758</endPage>

	 
      <doi>10.13005/bpj/1164</doi>
        <publisherRecordId>15066</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">HIV Infection: A Review of Their Inhibitors Progression</title>

    <authors>
	 


      <author>
       <name>Diksha Pandey</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Usha Chouhan</name>


		
	<affiliationId>1</affiliationId>

      </author>
    

	 


      <author>
       <name>Neha Verma</name>

		
	<affiliationId>1</affiliationId>
      </author>
    

	


	


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Department of Mathematics, Bioinformatics and Computer Applications Maulana Azad National Institute of Technology, Bhopal 462003, India.</affiliationName>
    

		
		
		
		
		
	  </affiliationsList>






    <abstract language="eng">This article provides a comprehensive recap of research on the basis of HIV infection, which is broad in worldwide. Human immunodeficiency virus (HIV) attacks the body's immune system, which is spread through the exchange of body fluids and unprotected sexual contact. HIV is extremely widespread diseases and results from a combination of defects in receptors assays and enzymatic assays, either of which may predominate. There are 33.3 million people worldwide, who suffered with HIV infection. The current prevalence of HIV infection is 0.26% of the India’s population and 0.8% in some countries. The present review gives a brief introduction to various stages, complications, therapeutic targets for receptors and enzymes and obtainable drugs which may activate or inhibit the receptors and enzymes responsible for causing AIDS.</abstract>

    <fullTextUrl format="html">https://biomedpharmajournal.org/vol10no2/hiv-infection-a-review-of-their-inhibitors-progression/</fullTextUrl>

<keywords language="eng">

      
        <keyword>Human immunodeficiency virus</keyword>
      

      
        <keyword> Receptors</keyword>
      

      
        <keyword> Enzymes</keyword>
      

      
        <keyword> Drugs</keyword>
      

      
        <keyword> AIDS</keyword>
      
</keywords>
  </record>
</records>